Stock Scorecard

Stock Summary for Capricor Therapeutics Inc (CAPR) - $31.43 as of 4/10/2026 7:03:23 PM EST

Total Score

8 out of 30

Safety Score

40 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CAPR

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CAPR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CAPR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CAPR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CAPR (40 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for CAPR

Company Overview
Ticker CAPR
Company Name Capricor Therapeutics Inc
Country USA
Description Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 12/31/2025
Next Earnings Date 5/12/2026

Stock Price History
Last Day Price 31.43
Price 4 Years Ago 3.86
Last Day Price Updated 4/10/2026 7:03:23 PM EST
Last Day Volume 686,539
Average Daily Volume 1,479,245
52-Week High 40.37
52-Week Low 4.30
Last Price to 52 Week Low 630.93%

Valuation Measures
Trailing PE N/A
Industry PE 43.01
Sector PE 38.13
5-Year Average PE -6.63
Free Cash Flow Ratio 6.27
Industry Free Cash Flow Ratio 14.85
Sector Free Cash Flow Ratio 22.07
Current Ratio Most Recent Quarter 9.01
Total Cash Per Share 5.01
Book Value Per Share Most Recent Quarter 5.33
Price to Book Ratio 6.04
Industry Price to Book Ratio 105.79
Sector Price to Book Ratio 23.58
Price to Sales Ratio Twelve Trailing Months 124.43
Industry Price to Sales Ratio Twelve Trailing Months 16.68
Sector Price to Sales Ratio Twelve Trailing Months 5.73
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 2

Share Statistics
Total Shares Outstanding 57,511,000
Market Capitalization 1,807,570,730
Institutional Ownership 54.05%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -159.58%
Reported EPS 12 Trailing Months -2.26
Reported EPS Past Year 0.00
Reported EPS Prior Year -2.26
Net Income Twelve Trailing Months -105,043,946
Net Income Past Year -105,043,946
Net Income Prior Year -40,467,186
Quarterly Revenue Growth YOY -7.90%
5-Year Revenue Growth -100.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 287,847,312
Total Cash Past Year 287,847,312
Total Cash Prior Year 11,286,996
Net Cash Position Most Recent Quarter 284,471,053
Net Cash Position Past Year 284,471,053
Long Term Debt Past Year 3,376,259
Long Term Debt Prior Year 3,376,259
Total Debt Most Recent Quarter 3,376,259
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 305,792,145
Total Stockholder Equity Prior Year 145,462,336
Total Stockholder Equity Most Recent Quarter 305,792,145

Free Cash Flow
Free Cash Flow Twelve Trailing Months -81,535,458
Free Cash Flow Per Share Twelve Trailing Months -1.42
Free Cash Flow Past Year -72,715,722,000
Free Cash Flow Prior Year -41,534,717

Options
Put/Call Ratio 1.86
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.87
MACD Signal 0.83
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.48
RSI 0.00
50-Day SMA 14.86
150-Day SMA 10.18
200-Day SMA 8.79

System
Modified 4/10/2026 7:55:58 PM EST